The NASP Education Committee welcomes submission of original or encore research relevant to specialty pharmacy, outcomes related to specialty pharmacy products, or services provided by specialty pharmacies. Accepted abstracts will be published online through the PubMed-indexed Journal of Drug Assessment. More details to come regarding an exciting virtual experience.

All abstracts must be submitted online here, using the template below, by July 17, 2020.

Submission Guidelines

At least one author must register for the 8th NASP Annual Meeting & Expo and be identified on the abstract submission as the presenting author.

Your abstract should be a short description of your research/work in specialty pharmacy, containing all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. Continuing education credits are not available for the posters.

Share your research or best practices with your peers. Categories of submission include:

  • Delivery of Specialty Pharmacy Products or Services
  • Adherence
  • Outcomes (Cost or Other)
  • Student Research
  • COVID-19 Products or Services
  • Best in Class

Note: Abstract submissions must reflect completed research. Submissions of previously presented research are permitted.

The Education Committee will evaluate the abstracts based on the following criteria: novelty of the research, significance of the findings, relevance to specialty pharmacy, and clarity. Incomplete abstracts will not be accepted.

Notification of acceptance, or regret, will be delivered via email to the presenter(s) of each poster abstract by August 3, 2020.

If your abstract has been previously presented at, or published for, a conference/congress, please include this information at the end of your abstract as "Previous Presentation/Publication." No permission is needed for encore publication in the 8th NASP Annual Meeting & Expo 2020 Research Presentation Abstracts book.

If accepted for presentation, abstracts and posters will be available for viewing during the virtual event at the 8th NASP Annual Meeting & Expo. More details to come regarding this virtual experience. Submission will also be published in the 8th NASP Annual Meeting & Expo 2020 Research Presentation Abstracts Book.

At least one author must register for the 8th NASP Annual Meeting & Expo and be identified on the abstract submission as the presenting author.

Abstract Format

  • The title of the abstract should be brief, objectively describing the study. Do not use non-standard abbreviations and commercial names (generic names only). Capitalize only the first word and any proper nouns.
  • No more than 10 authors can be listed with institutional affiliations, cities and countries only. Mailing addresses and academic degrees should not be mentioned in the author's list. For cooperative study groups, you may give the name of the group instead of individual institutional affiliations or include the name of the group in the title of the abstract.
  • Presenting Author: Details to follow. The Presenting Author will receive all future correspondence from the National Association of Specialty Pharmacy (NASP).
  • Abstracts limited to 2500 characters (abstract body, including spaces).
  • Abstracts should be structured in such a way as to include the following 5 sections:
    • Background/Significance – What was the problem and why was it important? What knowledge are you building on?
    • Objectives – What was the intent or goal of the study? What did you want to learn?
    • Methods – What was the trial design? What was the sample? What instruments were used? How was data collected and analyzed?
    • Results – What were the findings?
    • Conclusions – What do the findings mean?
  • Tables, illustrations, and/or figures are not allowed and will be deleted if submitted.
  • Abbreviations may be used if standard or if spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase). Compounds should be mentioned with the generic name, in lower cases. Commercial names may be included in the abstract text in parentheses with an ®, directly following the generic name at first use, i.e. "generic (Commercial ®)."
  • If an error is detected after submission, please notify Tiffany Fattizzi via email at abstracts@naspmeeting.com prior to the July 17, 2020, submission deadline to have the error corrected prior to the start of poster abstract review.
  • The abstract must be submitted in English.

Submission Process

You can submit your abstract here. After submission, a confirmation email will be sent to the submitter.

Abstract Questions

Please submit any questions pertaining to abstract submissions to abstracts@naspmeeting.com using the subject line "2020 NASP Annual Meeting Abstract Question."

Author Consent and Waiver of Claims

Each abstract author agrees and certifies that he or she:

  • Waives any and all claims against National Association of Specialty Pharmacy, sponsor of the National Association of Specialty Pharmacy 8th Annual Meeting & Expo, and any review arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.

Abstract Selected

If your abstract is accepted, the Presenting Author will receive all future correspondence from NASP.

2019 Abstract Winners

  • Adherence:
    • Appropriate Prescribing of Antiemetics With Oral Oncolytic Therapy: A Single Center Experience
    • Presented by Donna Capozzi
  • Outcomes:
    • Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic
    • Presented by Rachel Chelewski
  • Delivery of Specialty Pharmacy Product or Services:
    • Understanding Purchasing Patterns and Product Access of Newly Launched Specialty Generics
    • Presented by Stacey Ness
  • Top Poster – Attendee-Selected
    • Integrating High-Touch Specialty Pharmacy Services Within a Neurology Clinic to Improve Medication Access and Affordability
    • Presented by Amanda Hickman